ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia

被引：27
|
作者：
Menezes, J. [1 ]
Salgado, R. N. [1 ]
Acquadro, F. [1 ]
Gomez-Lopez, G. [2 ]
Carralero, M. C. [1 ]
Barroso, A. [3 ]
Mercadillo, F. [4 ]
Espinosa-Hevia, L. [1 ]
Talavera-Casanas, J. G. [5 ]
Pisano, D. G. [2 ]
Alvarez, S. [1 ]
Cigudosa, J. C. [1 ]
机构：
[1] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Mol Cytogenet Grp, Madrid, Spain
[2] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomput Program, Bioinformat Unit, Madrid, Spain
[3] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genet Grp, Madrid, Spain
[4] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Clin Familial Canc Unit, Madrid, Spain
[5] Ntra Sra de Candelaria Hosp, Hematol & Hemotherapy Serv, Santa Cruz De Tenerife, Spain
来源：
BLOOD CANCER JOURNAL | 2013年 / 3卷
关键词：
SOMATIC MUTATIONS; NPM1;
D O I：
10.1038/bcj.2013.54
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e157 / e157
页数：3
相关论文
共 50 条
  • [41] Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21)
    Duployez, Nicolas
    Micol, Jean-Baptiste
    Boissel, Nicolas
    Petit, Arnaud
    Geffroy, Sandrine
    Bucci, Maxime
    Lapillonne, Helene
    Renneville, Aline
    Leverger, Guy
    Ifrah, Norbert
    Dombret, Herve
    Abdel-Wahab, Omar
    Jourdan, Eric
    Preudhomme, Claude
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 199 - 200
  • [42] Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
    M M Patnaik
    T L Lasho
    P Vijayvargiya
    C M Finke
    C A Hanson
    R P Ketterling
    N Gangat
    A Tefferi
    Blood Cancer Journal, 2016, 6 : e385 - e385
  • [43] ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia
    Elliott, Michelle A.
    Pardanani, Animesh
    Hanson, Curtis A.
    Lasho, Terra L.
    Finke, Christy M.
    Belachew, Alem A.
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (07) : 653 - 656
  • [44] Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
    Patnaik, M. M.
    Lasho, T. L.
    Vijayvargiya, P.
    Finke, C. M.
    Hanson, C. A.
    Ketterling, R. P.
    Gangat, N.
    Tefferi, A.
    BLOOD CANCER JOURNAL, 2016, 6 : e385 - e385
  • [45] TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?
    Bomben, Riccardo
    Zucchetto, Antonella
    Pozzo, Federico
    Tissino, Erika
    Bittolo, Tamara
    Olivieri, Jacopo
    Chiarenza, Annalisa
    Zaja, Francesco
    Del Principe, Maria Ilaria
    Rossi, Davide
    Gattei, Valter
    HEMASPHERE, 2023, 7 (04):
  • [46] Prognostic Interaction Between ASXL1 and TET2 Mutations in Chronic Myelomonocytic Leukemia
    Patnaik, Mrinal M.
    Lasho, Terra L.
    Vijayvargiya, Pooja
    Finke, Christy
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Gangat, Naseema
    Tefferi, Ayalew
    BLOOD, 2015, 126 (23)
  • [47] HIGH-THROUGHPUT SEQUENCING FOR THE IDENTIFICATION OF TP53 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Barbieri, M.
    Favoino, C.
    Colombo, M.
    Manzoni, M.
    Cutrona, G.
    Matis, S.
    Fabris, S.
    Gentile, M.
    Recchia, A.
    Bossio, S.
    De Stefano, L.
    Fama, A.
    Vincoli, D.
    Musolino, C.
    Molica, S.
    Cortelezzi, A.
    Di Raimondo, F.
    Morabito, F.
    Ferrarini, M.
    Neri, A.
    Lionetti, M.
    HAEMATOLOGICA, 2016, 101 : S26 - S26
  • [48] TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia
    Lazarian, Gregory
    Theves, Floriane
    Hormi, Myriam
    Letestu, Remi
    Eclache, Virginie
    Bidet, Audrey
    Cornillet-Lefebvre, Pascale
    Davi, Frederic
    Delabesse, Eric
    Estienne, Marie-Helene
    Etancelin, Pascaline
    Kosmider, Olivier
    Laibe, Sophy
    Lode, Laurence
    Muller, Marc
    Nadal, Nathalie
    Naguib, Dina
    Pastoret, Cedric
    Poulain, Stephanie
    Sujobert, Pierre
    Veronese, Lauren
    Imache, Samia
    Lefebvre, Valerie
    Cymbalista, Florence
    Baran-Marszak, Fanny
    Soussi, Thierry
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (04) : E159 - E162
  • [49] Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations
    Fioretos, T
    Strömbeck, B
    Sandberg, T
    Johansson, B
    Billström, R
    Borg, Å
    Nilsson, PG
    Van den Berghe, H
    Hagemeijer, A
    Mitelman, F
    Höglund, M
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 69 - 69
  • [50] Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations
    Fioretos, T
    Strömbeck, B
    Sandberg, T
    Johansson, B
    Billström, R
    Borg, Å
    Nilsson, PG
    Van Den Berghe, H
    Hagemeijer, A
    Mitelman, F
    Höglund, M
    BLOOD, 1999, 94 (01) : 225 - 232
12345